A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

A new phase 3 trial reveals that combining enzalutamide and leuprolide significantly improves overall survival for men with ...

Men whose prostate cancer returns after surgery or radiation therapy may now benefit from a new drug combination shown in ...

A drug combination already used in advanced prostate cancer now appears to significantly extend survival when given earlier.

A new drug combination to treat advanced recurring prostate cancer has shown remarkable results in a long-term trial, ...

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

Drugs already in use could be combined to form a two-pronged attack on advanced prostate cancer, a study suggests.

Dr. Kent Perry answers the question: 'Predicting Prognosis Of Prostate Cancer?' March 16, 2009 -- Question: What predicts the prognosis of your prostate cancer? Answer: The prognosis of prostate ...

The 2025 ESMO annual meeting featured a metastatic castration-resistant prostate cancer (mCRPC) session and a presentation by ...

A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...

Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...